| AAV | Adeno-associated virus |
| ADL | Activity of daily living |
| BBB | Blood-brain barrier |
| BMD | Bone mineral density |
| BMT | Bone marrow transplantation |
| C6S | Chondroitin-6-sulfate |
| CBA | Chicken β-actin |
| CSF | Cerebrospinal fluid |
| CT | Computed tomography |
| D8 | Aspartic acid octapeptide |
| DBS | Dried blood spot |
| DMB | Dimethylmethylene blue |
| ECM | Extracellular matrix |
| ELISA | Enzyme-linked immunosorbent assay |
| EMA | European Medicines Agency |
| ERT | Enzyme replacement therapy |
| FDA | Food and Drug Administration |
| FEV1 | Forced expiratory volume in 1s |
| FVC | Forced vital capacity |
| GAG | Glycosaminoglycans |
| GALNS | N-acetylgalactosamine 6-sulfate sulfatase |
| GVHD | Graft versus host disease |
| HS | Heparan sulfate |
| HSCT | Hematopoietic stem cell transplantation |
| KS | Keratan sulfate |
| LC-MS/MS | Liquid chromatography tandem mass spectrometry |
| MPS | Mucopolysaccharidosis |
| MRI | Magnetic resonance imaging |
| NLC | Nanostructured lipid carriers |
| SDET | Substrate degradation enzyme therapy |